Table 1.
Baseline characteristics of participants who completed the 12 months follow-up.
Fig 1.
Participants who were lost to follow-up during the 12-month period were not included in the final analysis due to missing values for BP and LDL-C from the 12-month follow-up measurement. BP, blood pressure; LDL-C, low-density lipoprotein cholesterol; TIA, Transient Ischemic Attack. * 1 month post-discharge. † The LDL-C target value only concerned participants who had experienced an ischemic stroke.
Table 2.
Secondary preventive follow-up from baseline measurement (1 month after discharge) until 12 months after discharge.
Table 3.
SBP, DBP and LDL-C values at baseline, end of titration and at 12 months after discharge.
Fig 2.
Participants with SBP, DBP and LDL-C below the target level at baseline and at 12 months.
The lightly shaded portion of each 12 months stack represents the proportion of patients whose values changed from above target at baseline to below target at 12 months, whereas the dark shaded portion represents the proportion whose values remained below the target from baseline to 12 months. The differences observed between the intervention group and control group in the total proportion of participants with values below target at 12 months were significant with respect to SBP (p = 0.008) and LDL-C (p < 0.001). SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol.
Fig 3.
Effect of group allocation and baseline levels on the 12-month adjusted mean SBP, DBP and LDL-C.
Effect of the interaction between group allocation and the baseline level of BP or LDL-C on the 12-month adjusted mean (A) SBP (p = 0.001), (B) DBP (p = 0.054), or (C) LDL-C (p < 0.001) value. BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol.